Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-3092-2026

Fresenius Medical Care Renal Therapies Group, LLC recalls NaturaLyte

Fresenius Medical Care Renal Therapies Group, LLCWaltham, MA, United StatesReported Sep 9, 2026 · 6 days ago
Legal News Analyst ·

Reason for recall

Complaints of blue-green discoloration in product

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

NaturaLyte, Liquid Acid Concentrate for Bicarbonate Hemodialysis: Product Numbers: 08-1251-1, 08-2251-0, 08-2301-3, 08-3251-9, 08-3301-2, 13-2201-5, 13-2251-0, 13-3251-9; Liquid Acid Concentrate for Bicarbonate Hemodialysis

Lot / code information

Lot #
26AXAC056; 2) 08-2251-0, UDI/DI 00840861101696
Lot #
26AXAC050, 26BXAC012, 26BXAC042; 3) 08-2301-3, UDI/DI 00840861101702
Lot #
26BXAC013, 26BXAC045; 3) 08-3251-9, UDI/DI 00840861101740
Lot #
26AXAC051, 26BXAC011, 26BXAC043; 4) 08-3301-2, UDI/DI 00840861101757
Lot #
26AXAC052; 5) 13-2201-5, UDI/DI 00840861101849
Lot #
26AXAC062, 26AXAC064; 6) 13-2251-0, UDI/DI 00840861101863
Lot #
26AXAC041, 26AXAC058, 26AXAC059, 26AXAC065, 26BXAC001, 26BXAC003, 26BXAC005, 26BXAC034, 26BXAC049, 26BXAC051; 7) 13-3251-9, UDI/DI 00840861101887
Lot #
26BXAC037, 26BXAC048

What the firm is doing

Fresenius Medical Care issued an URGENT MEDICAL DEVICE RECALL to its consignees on 7/15/2026 via USPS first class mail. The notice explained the issue, potential risk and requested the following action: "1. Identify if you have any affected product lots on hand. 2. IMMEDIATELY segregate and discontinue use of affected lots. 3. Contact FMCRTG (1-833-203-5448) between 8:00 AM 8:00 PM Eastern daily, for return of affected lots and replacement of your stock. 4. Complete and return the attached REPLY FORM." For any clinical or medical questions, please contact the Global Medical Information and Education Office at 1-855-616-2309.

DistributionShow details

Worldwide distribution - US Nationwide and the country of Mexico.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls